SCHEMBL22640000

SCHEMBL22640000

Cc1noc(CNS(=O)(=O)c2ccc(Cl)cc2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ MAPT P10636 5/20 0.53
▸ CYP1A2 P05177 3/20 0.53
▸ CYP3A4 P08684 3/20 0.53
▸ CYP2D6 P10635 3/20 0.53
▸ CYP2C19 P33261 3/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ LMNA P02545 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ GAA P10253 1/20 0.50
▸ KCNJ1 P48048 1/20 0.50
▸ CYP19A1 P11511 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ EDNRB P24530 2/20 0.48
▸ EDNRA P25101 2/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18498694 0.86 MAPT (0.59) KMT2AMAPTTHRBGAACYP19A1
SCHEMBL22640138 0.82 NPC1 (0.57) MAPTHTTTHRBKCNJ1ALDH1A1
SCHEMBL22640139 0.82 NPC1 (0.57) MAPTHTTTHRBKCNJ1ALDH1A1
SCHEMBL22640166 0.72 ALDH1A1 (0.56) KMT2AMAPTHTTTHRBKCNJ1
SCHEMBL5960116 0.71 MEN1 (0.73) MEN1KMT2AMAPTCYP1A2CYP3A4
SCHEMBL22639780 0.70 KDM1A (0.48) MAPTCYP2C19CYP2C9ALDH1A1HSD17B10
SCHEMBL6505407 0.69 ALDH1A1 (0.68) MEN1KMT2ACYP2C9CYP19A1ALDH1A1
SCHEMBL15841263 0.69 SMN1; SMN2 (0.61) MAPTHTTLMNAGAAALDH1A1
SCHEMBL3885557 0.69 MAPT (0.55) MEN1KMT2AMAPTCYP1A2CYP3A4
SCHEMBL1287434 0.68 ALDH1A1 (0.70) MEN1KMT2ACYP1A2CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828281-B2 Non-hydrophobic compounds for use in treating metastasis and/or cartilage defect Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) 2020-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10828281-B2 Non-hydrophobic compounds for use in treating metastasis and/or cartilage defect VIM, MATR3, TP53 MEN1 935/4885KMT2A 4613/4885MAPT 168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback